- D1.1 Progress report on the accuracy, quality of data in the global database
- D1.2 Progress report on the implementation for a secure registry-to-registry communication system
- D2.1 Report on 2019 unrelated stem cell transplants
- D2.2 Report on import/export and registry operations within EU Member States
- D2.3 Defined education strategy for healthcare professionals in stem cell donation
- D2.4 Report on World Marrow Donor Day 2020
- D3.1 Online education materials for transplant centre physicians on SEAR reporting
- D3.2 Publication about the first year of the new software application and the importance of serious adverse events reporting
- D4.1 Webpage with materials of the workshop on data privacy standards
- D4.2 Progress report on the steps WMDA has taken to enhance the WMDA accreditation program including the strategy how to address organisations with low activity and how to certify the accreditation programme
- D4.3 Progress report on if it is feasible that WMDA will apply for ISO Certification
- D1.1 Progress report on the accuracy, quality of data in the global database 2021
- D1.2 Progress report on the implementation for a secure registry-to-registry communication system 2021
- D2.1 Report on 2020 unrelated stem cell transplants
- D2.2 Resources for registry operations and for import/export to EU Member States
- D2.3 Educational resources on registry operations during the pandemic
- D2.4 Report on World Marrow Donor Day 2021
- D3.1 Progress report on the WMDA online tool for reporting Serious Adverse Events and Reactions S(P)EARs)
- D3.2 WMDA 2020 annual report from the S(P)EAR committee
- D4.1 Annual Training Plan for reviewers
- D4.2 Progress report on on how to move forward accreditations in pandemic crisis
- D4.3 Progress report on if it is feasible that WMDA will apply for ISO Certification 2021